APA (7th ed.) Citation

Wagner, U., Marth, C., Largillier, R., Kaern, J., Brown, C., Heywood, M., . . . Lauraine, E. P. (2012). Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients. British Journal of Cancer, 107(4), 588. https://doi.org/10.1038/bjc.2012.307

Chicago Style (17th ed.) Citation

Wagner, U., et al. "Final Overall Survival Results of Phase III GCIG CALYPSO Trial of Pegylated Liposomal Doxorubicin and Carboplatin Vs Paclitaxel and Carboplatin in Platinum-sensitive Ovarian Cancer Patients." British Journal of Cancer 107, no. 4 (2012): 588. https://doi.org/10.1038/bjc.2012.307.

MLA (9th ed.) Citation

Wagner, U., et al. "Final Overall Survival Results of Phase III GCIG CALYPSO Trial of Pegylated Liposomal Doxorubicin and Carboplatin Vs Paclitaxel and Carboplatin in Platinum-sensitive Ovarian Cancer Patients." British Journal of Cancer, vol. 107, no. 4, 2012, p. 588, https://doi.org/10.1038/bjc.2012.307.